𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of a cholinomimetric drug (RS 86) in tardive dyskinesia and drug-related parkinsonism

✍ Scribed by U. Noring; U. Juul Povlsen; D. E. Casey; J. Gerlach


Publisher
Springer
Year
1984
Tongue
English
Weight
241 KB
Volume
84
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

✦ Synopsis


RS 86, a specific muscarinic agonist, was evaluated in a blind, placebo-controlled, single-dose trial in 10 psychiatric patients with stable tardive dyskinesia (TD). RS 86, 0.5-4 mg orally, produced no significant effects in TD, although 4 mg caused a minimal aggravation in parkinsonism. Side effects of the highest dose (4 mg) included hypersalivation (eight patients), nausea (6), sweating (3), and vomiting (3). It is concluded that treatment with RS 86 and probably other cholinomimetics has no or only limited beneficial effect in TD.


πŸ“œ SIMILAR VOLUMES


Effect of pulsatile administration of le
✍ Lance A. Smith; Michael J. Jackson; Matthew J. Hansard; Eleni Maratos; Peter Jen πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 143 KB

## Abstract Levodopa (L‐dopa) consistently primes basal ganglia for the appearance of dyskinesia in parkinsonian patients and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine hydrochloride (MPTP) ‐treated primates. This finding may reflect its relatively short duration of effects resulting in pulsatile

Plasma MHPG and AMDP depression relation
✍ F. Karege; Ph. Bovier; J.-M. Gaillard; R. Tissot πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 923 KB

Plasma MHPG levels and AMDP rating score were measured in depressed patients before treatment, and a follow-up study was performed during the next 3 months of drug therapy to detect possible relationships between the parameters. Before treatment, MHPG levels were moderately lower in depressed than i